C4 Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CCCC and other ETFs, options, and stocks.

About CCCC

C4 Therapeutics, Inc. engages in the development of targeted protein degradation science to develop a new generation of small molecule medicines used for treating diseases. It develops the Degronimid platform that incorporates small molecule binders to target disease-causing proteins and facilitate their destruction and clearance from the cell through the natural ubiquitin and proteasome system.

CEO

Andrew J. Hirsch

CEOAndrew J. Hirsch

Employees

110

Employees110

Headquarters

Watertown, Massachusetts

HeadquartersWatertown, Massachusetts

Founded

2015

Founded2015

Employees

110

Employees110

CCCC Key Statistics

Market cap

188.60M

Market cap188.60M

Price-Earnings ratio

-1.68

Price-Earnings ratio-1.68

Dividend yield

—

Dividend yield—

Average volume

977.83K

Average volume977.83K

High today

$2.74

High today$2.74

Low today

$2.64

Low today$2.64

Open price

$2.74

Open price$2.74

Volume

484.71K

Volume484.71K

52 Week high

$7.22

52 Week high$7.22

52 Week low

$1.09

52 Week low$1.09

Analyst ratings

71%

of 7 ratings

Buy

71.4%

Hold

28.6%

Sell

People also own

Based on the portfolios of people who own CCCC. This list is generated using Robinhood data, and it’s not a recommendation.